Diabetes und komorbide Depression: Systematische Literaturübersicht gesundheitsökonomischer Studien

 

 Buy Article Permissions and Reprints

Zusammenfassung

Anliegen Systematischer Literaturüberblick zu gesundheitsökonomischen Studien, in denen Diabetiker mit komorbider Depression untersucht wurden. Methode Literaturrecherche in PubMed und NHS EED im März 2011. Ergebnisse Die Ergebnisse der eingeschlossenen Krankheitskostenstudien (n = 8) zeigen, dass eine Depression zu erhöhten diabetesbezogenen Behandlungskosten führen kann, welche vermutlich auf Wechselwirkungen zwischen der depressiven Symptomatik und der Diabetestherapie zurückzuführen sind. Die Ergebnisse ökonomischer Evaluationen (n = 3) deuten an, dass geeignete Interventionen diese Zusatzkosten reduzieren beziehungsweise die aus der Intervention resultierenden zusätzlichen Kosten überkompensieren könnten. Schlussfolgerung Depressionen bei Diabetikern gehen mit zusätzlichen Versorgungskosten einher, welche sich durch geeignete Interventionen deutlich reduzieren lassen.

Abstract

Objective To conduct a systematic literature review of cost-of-illness studies and economic evaluations for diabetic patients with comorbid depression. Methods Systematic literature search in PubMed and NHS EED in March 2011, complemented by a bibliographic search within all eligible articles. Results The search produced a total of 388 studies of which 16 were analysed in full text. Altogether, eleven studies were included into the review, all of which were conducted in the USA. The results from cost-of-illness studies (n = 8) indicate excess costs in between 35 % and 300 % for diabetics with comorbid depression, in comparison to those without depression. Three economic evaluations indicate that appropriate interventions can lead to improved health (i. e. more depression free days) at no extra cost. The results from two cost-effectiveness analyses indicate dominance (more depression free days and cost-savings compared to „usual care“) for the evaluated interventions. Conclusions Depressive symptoms are associated with increased health care costs in diabetic patients. Part of these excess costs can be attributed to the treatment of diabetes. Appropriate interventions aimed at depression treatment can increase time free of depression at no greater cost than usual care.

Literatur

• 1 Diabetes.de. Deutscher Gesundheitsbericht Diabetes 2010.. Mainz: Kirchheim Verlag; 2010
  Google Scholar
• 2 König H H, Luppa M, Riedel-Heller S. Die Kosten der Depression und die Wirtschaftlichkeit ihrer Behandlung.  Psychiat Prax. 2010;  37 213-215
  Google Scholar
• 3 Stamm K, Reinhard I, Salize H J. Kosten und Kostenverläufe von Versicherten mit Depressionsdiagnose und ohne psychische Störung im Vergleich – eine Sekundäranalyse von Routinedaten einer Betriebskrankenkasse.  Neuropsychiatr. 2010;  24 99-107
  Google Scholar
• 4 van Dieren S, Beulens J W, van der Schouw Y T et al. The global burden of diabetes and its complications: an emerging pandemic.  Eur J Cardiovasc Prev Rehabil. 2010;  17 (S 01) 3-8
  Google Scholar
• 5 Egede L E, Ellis C. Diabetes and depression: global perspectives.  Diabetes Res Clin Pract. 2010;  87 302-312
  Google Scholar
• 6 Neumann N U, Frasch K. Zusammenhänge zwischen metabolischem Syndrom, Depression, Stress und körperlicher Aktivität.  Psychiat Prax. 2009;  36 110-114
  Google Scholar
• 7 Mantyselka P, Korniloff K, Saaristo T et al. Association of depressive symptoms with impaired glucose regulation, screen-detected, and previously known type 2 diabetes: findings from the Finnish D2D Survey.  Diabetes Care. 2011;  34 71-76
  Google Scholar
• 8 Vamos E P, Mucsi I, Keszei A et al. Comorbid depression is associated with increased healthcare utilization and lost productivity in persons with diabetes: a large nationally representative Hungarian population survey.  Psychosom Med. 2009;  71 501-507
  Google Scholar
• 9 Nichols L, Barton P L, Glazner J et al. Diabetes, minor depression and health care utilization and expenditures: a retrospective database study.  Cost Eff Resour Alloc. 2007;  5 4
  Google Scholar
• 10 Anderson R J, Freedland K E, Clouse R E et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis.  Diabetes Care. 2001;  24 1069-1078
  Google Scholar
• 11 Lustman P J, Anderson R J, Freedland K E et al. Depression and poor glycemic control: a meta-analytic review of the literature.  Diabetes Care. 2000;  23 934-942
  Google Scholar
• 12 Simon G E, Katon W J, Lin E H et al. Diabetes complications and depression as predictors of health service costs.  Gen Hosp Psychiatry. 2005;  27 344-351
  Google Scholar
• 13 de Groot M, Anderson R, Freedland K E et al. Association of depression and diabetes complications: a meta-analysis.  Psychosom Med. 2001;  63 619-630
  Google Scholar
• 14 Ciechanowski P S, Katon W J, Russo J E. Depression and diabetes – Impact of depression symptoms on adherence, function, costs.  Arch Int Med. 2000;  160 3278-3285
  Google Scholar
• 15 Korff M von, Katon W, Lin E H et al. Potentially modifiable factors associated with disability among people with diabetes.  Psychosom Med. 2005;  67 233-240
  Google Scholar
• 16 Egede L E. Diabetes, major depression, and functional disability among U.S. adults.  Diabetes Care. 2004;  27 421-428
  Google Scholar
• 17 Schram M T, Baan C A, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium.  Curr Diabetes Rev. 2009;  5 112-119
  Google Scholar
• 18 Moussavi S, Chatterji S, Verdes E et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys.  Lancet. 2007;  370 851-858
  Google Scholar
• 19 Katon W, Fan M Y, Unutzer J et al. Depression and diabetes: a potentially lethal combination.  J Gen Intern Med. 2008;  23 1571-1575
  Google Scholar
• 20 Lin E H, Heckbert S R, Rutter C M et al. Depression and increased mortality in diabetes: unexpected causes of death.  Ann Fam Med. 2009;  7 414-421
  Google Scholar
• 21 Subramaniam M, Sum C F, Pek E et al. Comorbid depression and increased health care utilisation in individuals with diabetes.  Gen Hosp Psychiatry. 2009;  31 220-224
  Google Scholar
• 22 Finkelstein E A, Bray J W, Chen H et al. Prevalence and costs of major depression among elderly claimants with diabetes.  Diabetes Care. 2003;  26 415-420
  Google Scholar
• 23 Kalsekar I D, Madhavan S M, Amonkar M M et al. The effect of depression on health care utilization and costs in patients with type 2 diabetes.  Manag Care Interface. 2006;  19 39-46
  Google Scholar
• 24 Katon W J, Simon G, Russo J et al. Quality of depression care in a population-based sample of patients with diabetes and major depression.  Med Care. 2004;  42 1222-1229
  Google Scholar
• 25 Egede L E, Zheng D, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes.  Diabetes Care. 2002;  25 464-470
  Google Scholar
• 26 Le T K, Able S L, Lage M J. Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression.  Cost Eff Resour Alloc. 2006;  4 18
  Google Scholar
• 27 Simon G E, Katon W J, Lin E HB et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.  Arch Gen Psychiatry. 2007;  64 65-72
  Google Scholar
• 28 Katon W J, Russo J E, Korff M von et al. Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes.  Diabetes Care. 2008;  31 1155-1159
  Google Scholar
• 29 Katon W, Unutzer J, Fan M Y et al. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression.  Diabetes Care. 2006;  29 265-270
  Google Scholar
• 30 OECD .OECD Health Data.. OECD; 2010
  Google Scholar
• 31 Unutzer J, Schoenbaum M, Katon W J et al. Healthcare costs associated with depression in medically Ill fee-for-service medicare participants.  J Am Geriatr Soc. 2009;  57 506-510
  Google Scholar
• 32 Egede L E. Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes.  Curr Diabetes Rev. 2005;  1 235-243
  Google Scholar
• 33 Egede L E, Ellis C, Grubaugh A L. The effect of depression on self-care behaviors and quality of care in a national sample of adults with diabetes.  Gen Hosp Psychiatry. 2009;  31 422-427
  Google Scholar
• 34 Korff M von, Ludman E, Katon W et al. Work disability among individuals with diabetes.  Diabetes Care. 2005;  28 1326-1332
  Google Scholar
• 35 Egede L E, Ellis C. The effects of depression on diabetes knowledge, diabetes self-management, and perceived control in indigent patients with type 2 diabetes.  Diabetes Technol Ther. 2008;  10 213-219
  Google Scholar
• 36 Petrak F, Herpertz S. Treatment of depression in diabetes: an update.  Curr Opin Psychiatry. 2009;  22 211-217
  Google Scholar
• 37 van der Feltz-Cornelis C M, Nuyen J, Stoop C et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis.  Gen Hosp Psychiatry. 2010;  32 380-395
  Google Scholar
• 38 Kahl K G, Lampen-Inkamp S, Gollner K et al. Pharmakotherapie der Depression bei Menschen mit Diabetes.  Diabetologe. 2010;  6 280
  Google Scholar
• 39 König H H. Gesundheitsökonomische Evaluation.. In: Roeder N, Hensen P, Hrsg Gesundheitsökonomie, Gesundheitssystem und öffentliche Gesundheitspflege. Kurzlehrbuch für Studierende der Medizin.. Köln: Deutscher Ärzteverlag; 2008: 123-143
  Google Scholar
• 40 Lehnert T, Konnopka A, Riedel-Heller S et al. Gesundheitsökonomische Aspekte psychischer Komorbidität bei somatischen Krankheiten.  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011;  54 120-127
  Google Scholar
• 41 Chernyak N C, Icks A, Scheer M et al. Gesundheitsökonomische Evaluationen von Interventionen bei Diabetes mellitus und komorbider depression.  Diabetologe. 2011;  7 88-91
  Google Scholar
• 42 Luppa M, Heinrich S, Matschinger H et al. Direct costs associated with depression in old age in Germany.  J Affect Disord. 2008;  105 195-204
  Google Scholar
• 43 Rowan P J, Davidson K, Campbell J A et al. Depressive symptoms predict medical care utilization in a population-based sample.  Psychol Med. 2002;  32 903-908
  Google Scholar
• 44 Arnow B A, Blasey C M, Lee J et al. Relationships Among Depression, Chronic Pain, Chronic Disabling Pain, and Medical Costs.  Psychiatr Serv. 2009;  60 344-350
  Google Scholar
• 45 Sayers S L, Hanrahan N, Kutney A et al. Psychiatric comorbidity and greater hospitalization risk, longer length of stay, and higher hospitalization costs in older adults with heart failure.  J Am Geriatr Soc. 2007;  55 1585-1591
  Google Scholar
• 46 Johansson P A, Farup P G, Bracco A et al. How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.  BMC Gastroenterol. 2010;  10 31
  Google Scholar
• 47 Friederich H C, Hartmann M, Bergmann G et al. Psychische Komorbidität bei internistischen Krankenhauspatienten.  Psychother Psychosom Med Psychol. 2002;  52 323-328
  Google Scholar
• 48 Baumeister H, Härter M. Auswirkungen komorbider Störungen bei chronischen körperlichen Erkrankungen.  Z Med Psychol. 2005;  14 1-15
  Google Scholar
• 49 Baumeister H, Balke K, Harter M. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients.  J Clin Epidemiol. 2005;  58 1090-1100
  Google Scholar
• 50 Fagiolini A, Goracci A. The Effects of Undertreated Chronic Medical Illnesses in Patients With Severe Mental Disorders.  J Clin Psychiatry. 2009;  70 22-29
  Google Scholar

Dipl.-Soz. Thomas Lehnert

Institut für Medizinische Soziologie, Sozialmedizin und Gesundheitsökonomie (IMSG), Universitätsklinikum Hamburg-Eppendorf

Martinistraße 52

20246 Hamburg

Email: t.lehnert@uke.uni-hamburg.de